Core Insights - Angelalign Technology Co., Ltd. reported a strong performance in its mid-year results for 2025, with a 47.7% year-on-year increase in total cases of invisible orthodontics, reaching approximately 225,800 cases [1] - The company's revenue, gross profit, and operating profit all saw year-on-year increases, driven by the growth in case numbers and efficient operations of its medical design center and production base [1] - The company implemented strict cost control measures in response to uncertainties in the tariff environment, which included delaying recruitment in sales, marketing, clinical support, and customer service, as well as postponing the operation of its international medical design center and production base [1] Financial Performance - For the reporting period, Angelalign's revenue grew by 33.1% year-on-year to approximately $161.4 million, with gross profit reaching $100.6 million and adjusted net profit at $19.5 million [1] - The international market saw a significant increase in case numbers, reaching 117,200 cases, a year-on-year growth of 103.5%, attributed to both a low base from the previous year and successful market expansion efforts [2] - In the Chinese market, the number of cases reached 108,600, reflecting a year-on-year growth of 14% [2] Strategic Initiatives - The company plans to strategically increase long-term investments in key areas to establish a more sustainable global business foundation [1] - Future investments will focus on enhancing sales and marketing, clinical support, and customer service, as well as establishing and operating international medical design centers and manufacturing bases [1] - Angelalign aims to strengthen its legal capabilities to advance its intellectual property strategy and compliance efforts, while also upgrading data security infrastructure to solidify its market position [1][2]
时代天使上半年收入同比增长33.1% 持续强化供应链和数据安全